Breaking News

Vitruvias and Bora Form Contract Manufacturing Agreement

Vitruvias licenses Potassium Chloride ER ANDA capsules to be manufactured at Bora’s new Zhunan facility in Taiwan

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Vitruvias Therapeutics, an Auburn, AL-based finished-dose generic drug development company, has agreed to license an approved Potassium Chloride Extended release ANDA. The product will be manufactured by contract development and manufacturing organization (CDMO) Bora Pharmaceutical’s Zhunan site, which was recently acquired from Impax.   “As a 40-year veteran if this industry, I have toured many manufacturing facilities, and Bora’s Zhunan facility is one of the best I have ever seen,” said Car...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters